Role of arachidonic acid metabolism in thymocyte apoptosis after irradiation  by Korystov, Yuri N. et al.
FEBS Letters 388 (1996) 238-241 FEBS 17149 
Role of arachidonic acid metabolism in thymocyte apoptosis after 
irradiation 
Yuri N. Korystov*, Oksana R. Dobrovinskaya, Vera V. Shaposhnikova, Lazar Kh. Eidus 
Laboratory of Cell Radiobiology, Institute of Theoretical nd Experimental Biophysics, 
Russian Academy of Sciences, Pushchino 142292, Russian Federation 
Received 22 April 1996 
Abstract The present study demonstrates that DNA fragmen- 
tation, nuclear pycnosis and trypan blue staining of irradiated 
thymocytes is prevented by inhibition of the lipoxygenase 
pathway of arachidonic acid metabolism and is not affected by 
cyclooxygenase inhibition. Exposed to irradiation [3H]arachido- 
nic acid-labeled thymocytes release radioactive products to the 
external medium. The process is blocked by the lipoxygenase 
inhibitor, nordihydroguaiaretic acid. Thus, it can be concluded 
that irradiation activates arachidonic acid metabolism and that 
lipoxygenase metabolites play an important role in thymocyte 
apoptosis. 
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1. Introduction 
The biochemical regulation of programmed cell death 
(apoptosis) has recently attracted a great attention because 
of its role in many normal processes and pathological condi- 
tions [1,2]. Apoptosis can be initiated by various inducers uch 
as corticoids, quinone compounds, by triggering of cytokine 
receptors, deprivation of growth factors and ionizing radia- 
tion [3]. The apoptotic death of irradiated thymocytes is de- 
pendent on their interactions occurring via as yet unknown 
mediators [4,5]. The AA metabolites are likely candidates for 
this role. These compounds are of great importance in the 
regulation of different immune reactions where the interac- 
tions between specialized cells take place [6-8]. A variety of 
cell types involved is known to have extracellular specific re- 
ceptors to AA metabolites [9,10]. PLA2, a catalyzer of the 
hydrolysis of choline and ethanolamine glycerophospholipid, 
is the key enzyme responsible for AA release at different sig- 
nal reactions in mammalian cells [11-13]. The released AA is 
consequently oxidized either by cyclooxygenase with forma- 
tion of cyclic products like prostaglandins, or by lipoxygenase 
giving rise to linear chain products such as lipoxines and 
leukotrienes [8,13]. Previously we have shown that BPB, a 
PLA2 inhibitor [11], prevents nuclear pycnosis [5] and DNA 
fragmentation [14] in irradiated thymocytes. Nuclear pycnosis 
was the only criterion of the effects of lipoxygenase and cy- 
clooxygenase inhibitors [5]. Nuclear pycnosis (or chromatin 
condensation) and intemucleosomal DNA fragmentation are 
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known to have different metabolic pathways [15,16]. There- 
fore different criteria of apoptosis are needed to determine the 
role of metabolic pathways in the whole process. 
The purpose of this work is to study the effects of cyclooxy- 
genase and lipoxygenase inhibitors on DNA fragmentation, 
chromatin condensation and membrane damage in irradiated 
thymocytes as well as the kinetics of AA metabolites release 
from thymocytes after irradiation. 
2. Materials and methods 
Thymocytes were isolated from male Wistar rats (130-150 g) by a 
standard procedure [4]. Cells were suspended in Hanks' balanced salt 
solution with 20 mM HEPES at 37°C, washed once, and resuspended 
in Hanks' solution to obtain a final concentration of 1.5 × 107 cells/ml. 
Then the cells were irradiated with 6°Co y-rays at a dose rate of 3.2 
Gy/min at room temperature. The postirradiation incubation was 
carried out in 96-well fiat-bottomed plates at 200 Ixl/well at 37°C in 
Hanks' solution. We abandoned postirradiation i cubation of thymo- 
cytes in nutrient media (RPMI 1640) as this medium greatly decreased 
the cell death tested with trypan blue [15]. 
Cell death was evaluated by the decrease in cell number (cell lysis) 
and by staining of cells in a 0.04% solution of the trypan blue dye 
(Serva) after 24 h incubation [4]. Pycnotic cells were identified with 
acetic acid~ethanol (1:3) fixation and Giemsa staining after 6 h in- 
cubation. 
DNA fragmentation was determined 6 h after postirradiation i cu- 
bation according to [17]. Cells (approximately 1.5x 107 cells) were 
scraped from culture plates, isolated by centrifugation for 10 min at 
700×g, resuspended in 1 ml of a lysis buffer containing 5 mM Tris- 
HC1, 20 mM EDTA, 0.5% Triton X-100, pH 8.0, and allowed to lyse 
for 15 min on ice. Samples were then centrifuged at 13000Xg for 25 
min to separate high molecular weight chromatin (pellet) from cleav- 
age products (supernatant). Pellets were resuspended in 1 ml of buffer 
solution containing 10 mM Tris-HC1 and 1 mM EDTA, pH 8.0. 
Pellets and supernatant were assayed for DNA content using the 
diphenylamine r agent [18]. DNA staining with diphenylamine was 
performed at 30°C for 17-20 h. DNA content was evaluated from 
absorption at a wavelength of 600 nm. The percentage of DNA frag- 
mentation was determined as the ratio of optical density in the super- 
natant to the sum of optical densities in the supernatant and the 
pellet. 
The damage of irradiated thymocytes was modified by addition of 
indomethacin and NDGA, purchased from Serva (Heidelberg, Ger- 
many). Stock solutions of indomethacin and NDGA in DMSO were 
used. These compounds were used at conventional concentrations 
[19,20]. They were added into the cell suspensions prior to irradiation 
and allowed to remain there throughout the incubation period: 6 h 
for determination of nuclear pycnosis and DNA fragmentation and 
24 h for determination of the cell death. 
The thymocytes (1.5× 107 cells/ml) were labelled in 3 ml RPMI 
1640 medium supplemented with 1% bovine serum and 1 ~tCi/ml 
[3H]arachidonic acid (150 Ci/mM; 6.7 nM) for 1 h at 37°C as de- 
scribed previously [21,22]. After the incubation, the supernatant was 
removed, and the cells were washed three times with RPMI 1640 
supplemented with 0.5% albumin and once with Hanks' solution. 
The incorporation of radioactivity into the cells approximated 
2.5 x 10 4 cpm per 10 6 cells. Labelled cells were exposed to irradiation, 
and cell suspensions in Hanks' solution (5-10× 106 cells/ml) were in- 
cubated over different periods of time in glass tubes at 370C and then 
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Fig. 1. Effects of indomethacin (a) and NDGA (b) on cell death 
(zx, • )  and nuclear pycnosis (©, O) of 6 Gy irradiated (©, ,x ) and 
control (@, • )  thymocytes; for the cell death n = 2 and for nuclear 
pycnosis n = 4. 
were centrifuged at 4000 × g for 5 min. Radioactivity released into the 
medium in the course of cell incubation was evaluated by counting of 
the supernatant aliquots (150 gl). Just prior to incubation the radio- 
activity release was 325 _+ 35 cpm per 10 a cells which was taken as 
reference point and this value was subtracted from all the subsequent 
values. Points in the graphs are means ± standard deviation (n > 3). 
The number of assays (n) for each experiment is indicated in the figure 
legends. 
3. Resu l t s  and  d i scuss ion  
As shown in Figs. lb and 2, NDGA,  an inhibitor of the 
lipoxygenase pathway [23], decreased nuclear pycnosis, cell 
death and DNA fragmentation i a dose dependent manner. 
NDGA decreased cell death and DNA fragmentation i con- 
trol also at concentrations above 20 gM. At the same time, 
indomethacin, which is known to cause specific blockage of 
cyclooxygenase at a concentration of 1 gM [19], had no effect 
on all apoptosis criteria up to a concentration of  100 gM (Fig. 
l a, Fig. 2). To exclude antioxidant activity of NDGA [24] in 
apoptosis we checked the effects of other antioxidants. Ionole 
(10 -4 M), ct-tocopherol (6 × 10 -4 M), and ascorbic acid (10 -4 
M) did not affect DNA fragmentation (data not shown). This 
control confirmed that NDGA affects apoptosis via lipoxy- 
genase inhibition. Taken together these data and the apopto- 
sis prevention with the PLA2 inhibitor [5,14] suggest involve- 
ment of the lipoxygenase branch of AA  metabolism in 
radiation-induced and in vitro incubation-induced apoptosis 
of thymocytes. Involvement of the lipoxygenase pathway in 
tumor cell apoptosis mediated by tumor necrosis factor was 
recently shown [25]. 
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Fig. 2. Effects of indomethacin and NDGA on DNA fragmentation. 
1, control; 2, 6 Gy; 3, 6 Gy+l gM indomethacin; 4, 6 Gy+10 gM 
indomethacin; 5, 6 Gy+100 I.tM indomethacin; 6, 6 Gy+20 gM 
NDGA; 7, 40 gM NDGA; 8, 6 Gy+40 gM NDGA. n = 3~. Indo- 
methacin had no effect on DNA fragmentation i control; 20 gM 
NDGA decreased DNA fragmentation insignificantly, up to 
13±4%. 
The radiation activation of AA  metabolism was confirmed 
using a complementary approach, by measurements of radio- 
activity release from irradiated thymocytes preincubated with 
all-labeled AA. Calcium ionophore A23187 is known to be an 
activator of PLA2 and AA release from membrane [21]. 
Hence, treatment with 0.1 gM A23187 was used as a control 
to support that 3H-labeled AA had been incorporated into 
membrane. The radioactivity release from thymocytes treated 
with A23187 was about 3000 cpm per 106 cells 60 min after 
stimulation, which was approximately 10 12% of the total 
radioactivity incorporation, being in agreement with [21]. 
The kinetics of radioactivity release from 6 Gy irradiated thy- 
mocytes isolated from different rats varied greatly. The differ- 
ent types of responses are shown in Fig. 3. In seven experi- 
ments out of 24 the radioactivity release was close to that in 
the control. In other cases the release of labeled products was 
observed, and reached its maximum at 30-60 min after irra- 
diation. 
The data variability could be caused partly by changes in 
some experimental conditions from day to day. Therefore four 
rats were examined in one day. Nuclear pycnosis and death of 
thymocytes after irradiation were found to be identical for all 
the rats tested, but irradiation stimulation of radioactivity 
release was observed in thymocytes from three rats only 
with a maximum at 30 min (two rats) and 60 min (one rat), 
which was 3-4 times more than the control level. The absence 
Table 1 
Effect of NDGA (20 gM) on 3H-radioactivity release by irradiated thymocytes a 
Time 3H-radioactivity release (cprn/106 cells) 
(rain) control c Exp. 1 Exp. 2 Exp. 3 
6Gy 6Gy+NDGA 6Gy 6Gy+NDGA 6Gy 6Gy+NDGA 
30 69 ± 15 169 113 8217 0 b 237 82 
60 108 ± 20 168 95 257 33 162 0 b 
~The data of three experiments with significant 3H-radioactivity release after irradiation are presented. 
bThe values are the same as those obtained prior to incubation (325 + 35 cprn/106 cells). 
CThe values given are the averages of 24 experiments + SD. 
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of an increase in labeled products in the medium after irradia- 
tion of thymocytes could be explained by the enhanced capa- 
city of the thymocytes to reabsorb AA in this case. To check 
it we used fatty acid free albumin which is known to suppress 
cell reabsorption of AA and its metabolites [26]. The addition 
of albumin to the thymocyte suspension strongly increased the 
radioactivity release, being more pronounced for irradiated 
cells (Fig. 4). The release kinetics was changed to a monotonic 
one in the presence of albumin. These data show that radia- 
tion stimulates AA metabolism in thymocytes from all rats 
but in some cases the effect is not revealed in the absence of 
albumin. The cell reabsorption of AA and its metabolites i
caused by AA reacylation [26] and binding of AA metabolites 
to the receptors at the cell surface [9,10]. Variations in these 
processes in the thymocytes from different rats remain an 
open question, but such variation is in the usual run of things 
when the radioactivity release from irradiated lymphoid cells 
preincubated with labeled AA was studied in incubation med- 
ium [27]. 
The addition of NDGA to the cells with pronounced release 
of labeled products prevented this process (Table 1). This 
implies that the bulk of releasing products could be lipoxy- 
genase metabolites. For example, in platelets 10 s after stimu- 
lation only 20-25% of 3H label iberated was still the free acid, 
the rest having been converted to products of cyclooxygenase 
and lipoxygenase [26], and lipoxygenase products predomi- 
nantly [28]. In addition the decreased release of lipoxygenase 
metabolites in the presence of inhibitor can suppress [3H]AA 
release also because PLA2 activity depends on protein kinase 
C [29] and leukotrienes activate the latter [30]. The kinetics of 
radioactivity release is also consistent with the behavior of 
lipoxygenase metabolites found with the activation of leuko- 
cytes and lymphocytes by other stimuli. The maximal release 
was usually observed 5-10 min after cell activation, whereas 
most of the products remained bound to the cells or reab- 
sorbed after release by the receptors at the surface of the 
cell membrane [10,31,32]. 
In conclusion, the work presented here shows that irradia- 
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Fig. 3. Time course of radioactivity release by 6 Gy irradiated thy- 
mocytes. The zero time point is taken in the beginning of incuba- 
tion at t = 37°C. Values of radioactivity release by unirradiated thy- 
mocytes (o) are plotted as mean + SD (n = 24). The radioactivity 
release by irradiated thymocytes i  presented as data of individual 
experiments; he values given are the averages of duplicates. 
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Fig. 4. Time course of radioactivity release by control (O, • ) and 6 
Gy irradiated (O, zx) thymocytes in Hanks' solution (O, (3) and 
that supplemented with 40 mg/ml fatty acid free albumin (• ,  zx). 
tion of thymocytes leads to activation of AA metabolism, and 
that lipoxygenase metabolites play an important role in radia- 
tion-induced thymocyte apoptosis. 
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